Figure 8
From: Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma
CTTN relative magnitudes of no cancer embolus and metastasis group, cancer embolus or metastasis group, and control group.
Figure 8 | World Journal of Surgical Oncology